Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study.

× No keyword cloud information.

22 in total

Review 1. Highlights of the year in JACC 2012.

Authors: Anthony N DeMaria; Jeroen J Bax; Gregory K Feld; Barry H Greenberg; Jennifer L Hall; Mark A Hlatky; Wilbur Y W Lew; João A C Lima; Ehtisham Mahmud; Alan S Maisel; Sanjiv M Narayan; Steven E Nissen; David J Sahn; Sotirios Tsimikas
Journal: J Am Coll Cardiol Date: 2013-01-22 Impact factor: 24.094

2. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal: Circulation Date: 2014-03-28 Impact factor: 29.690

Review 3. Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model.

Authors: Hooman Kamel; Peter M Okin; Mitchell S V Elkind; Costantino Iadecola
Journal: Stroke Date: 2016-01-19 Impact factor: 7.914

Review 4. Thromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: A systematic review and meta-analysis.

Authors: Alessio Lilli; Andrea Di Cori; Valerio Zacà
Journal: Clin Cardiol Date: 2017-05-04 Impact factor: 2.882

5. Combined aspirin and anticoagulant therapy in patients with atrial fibrillation.

Authors: Charlotte H So; Mark H Eckman
Journal: J Thromb Thrombolysis Date: 2017-01 Impact factor: 2.300

Review 6. Target-specific oral anticoagulants in atrial fibrillation: results of phase III trials and comments on sub-analyses.

Authors: Simon Mantha
Journal: J Thromb Thrombolysis Date: 2013-08 Impact factor: 2.300

7. A single centre experience of the efficacy and safety of dabigatran etexilate used for stroke prevention in atrial fibrillation.

Authors: Lok Bin Yap; Beni Isman Rusani; Dhanan Umadevan; Zulkeflee Muhammad; Azlan Hussin; Surinder Kaur; Razali Omar
Journal: J Thromb Thrombolysis Date: 2014-07 Impact factor: 2.300

8. Automatically finding relevant citations for clinical guideline development.

Authors: Duy Duc An Bui; Siddhartha Jonnalagadda; Guilherme Del Fiol
Journal: J Biomed Inform Date: 2015-09-10 Impact factor: 6.317

9. Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.

Authors: Mark H Eckman; Gregory Y H Lip; Ruth E Wise; Barbara Speer; Megan Sullivan; Nita Walker; Brett Kissela; Matthew L Flaherty; Dawn Kleindorfer; Peter Baker; Robert Ireton; Dave Hoskins; Brett M Harnett; Carlos Aguilar; Anthony Leonard; Lora Arduser; Dylan Steen; Alexandru Costea; John Kues
Journal: J Am Geriatr Soc Date: 2016-05 Impact factor: 5.562

10. Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48.

Authors: Deepak K Gupta; Amil M Shah; Robert P Giugliano; Christian T Ruff; Elliott M Antman; Laura T Grip; Naveen Deenadayalu; Elaine Hoffman; Indravadan Patel; Minggao Shi; Michele Mercuri; Veselin Mitrovic; Eugene Braunwald; Scott D Solomon
Journal: Eur Heart J Date: 2013-12-02 Impact factor: 29.983